|
1) Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005; 46: 1768-76
|
|
|
|
2) Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59: 17-20
|
|
|
|
|
|
3) Opotowsky AR, Landzberg MJ, Kimmel SE, et al. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA. 2008; 299: 521-2
|
|
|
|
|
|
4) Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988; 318: 1148-52
|
|
|
|
|
|
5) Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology. 2000; 55: 1172-9
|
|
|
|
|
|
6) Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007; 357: 2262-8
|
|
|
|
|
|
7) Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985; 6: 1370-82
|
|
|
|
|
|
8) Sugaya T, Yasu T, Fujii M, et al. Effect of atrial septal aneurysm on risk of cerebrovascular events in Japanese patients. Int J Cardiol. 2004; 93: 253-6
|
|
|
|
|
|
9) Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005; 112: 1063-72
|
|
|
|
|
|
10) Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345: 1740-6
|
|
|
|
|
|
11) Bonati LH, Kessel-Schaefer A, Linka AZ, et al. Diffusion-weighted imaging in stroke attributable to patent foramen ovale: significance of concomitant atrial septum aneurysm. Stroke. 2006; 37: 2030-4
|
|
|
|
|
|
12) Schuchlenz HW, Weihs W, Horner S, et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med. 2000; 109: 456-62
|
|
|
|
|
|
13) Van Camp G, Cosyns B, Vandenbossche JL. Non-smoke spontaneous contrast in left atrium intensified by respiratory manoeuvres: a new transoesophageal echocardiographic observation. Br Heart J. 1994; 72: 446-51
|
|
|
|
|
|
14) Schuchlenz HW, Weihs W, Beitzke A, et al. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke. 2002; 33: 293-6
|
|
|
|
|
|
15) Johansson MC, Helgason H, Dellborg M, et al. Sensitivity for detection of patent foramen ovale increased with increasing number of contrast injections: a descriptive study with contrast transesophageal echocardiography. J Am Soc Echocardiogr. 2008; 21: 419-24
|
|
|
|
|
|
16) Cabanes L, Coste J, Derumeaux G, et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Interobserver and intraobserver variability in detection of patent foramen ovale and atrial septal aneurysm with transesophageal echocardiography. J Am Soc Echocardiogr. 2002; 15: 441-6
|
|
|
|
|
|
17) Meissner I, Khanderia BK, Heit JA, et al. Patent foramen ovale: innocent or guilty？ Evidence from a prospective population-based study. J Am Coll Cardiol. 2006; 47: 440-5
|
|
|
|
|
|
18) Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007; 49: 797-802
|
|
|
|
|
|
19) Sacco RL, Adams R, Albers G, et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006; 37: 577-617
|
|
|
|
|
|
20) Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation. 2002; 105: 2625-31
|
|
|
|
|
|
21) Opotowsky AR, Landzberg MJ, Kimmel SE, et al. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998-2004. JAMA. 2008; 299: 521-2
|
|
|
|
|
|
22) Dowson AJ, Mullen M, Peatfield R, et al. Migraine Intervention with STARFlex Technology trial: a prospective, multicentre, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008; 117: 1397-404
|
|
|
|
|
|
23) Amin Z, Hijazi ZM, Bass JL, et al. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv. 2008; 72: 74-9
|
|
|
|
|
|
24) Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004; 44: 750-8
|
|
|
|
|
|
25) Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003; 139: 753-60
|
|
|
|
|
|
26) Majunke N, Sievert H. ASD/PFO devices: what is in the pipeline？ J Interv Cardiol. 2007; 20: 517-23
|
|
|
|
|